Drug interactions won't exclude HCV transplant or HIV co-infected patients from treatment
New data from a number of clinical trials presented for the first time at the International Liver Congress 2012 provides hope for previously difficult to treat hepatitis C (HCV) patient populations.
Apr 19, 2012
0
0